{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:44:19Z","timestamp":1774712659979,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00213-020-05543-7","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T18:04:11Z","timestamp":1589997851000},"page":"2405-2418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice"],"prefix":"10.1007","volume":"237","author":[{"given":"Amelia","family":"Dunn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Ben-Ezra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Pikus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Morochnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Erazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"5543_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jcpt.12404","volume":"41","author":"A Albert-Vartanian","year":"2016","unstructured":"Albert-Vartanian A, Boyd MR, Hall AL et al (2016) Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? J Clin Pharm Ther 41:371\u2013382. https:\/\/doi.org\/10.1111\/jcpt.12404","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"5543_CR2","first-page":"42","volume":"43","author":"JP Balcombe","year":"2004","unstructured":"Balcombe JP, Barnard ND, Sandusky C (2004) Laboratory routines cause animal stress. Contemp Top Lab Anim Sci 43(6):42\u201351","journal-title":"Contemp Top Lab Anim Sci"},{"key":"5543_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002130000569","volume":"153","author":"MT Bardo","year":"2000","unstructured":"Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31\u201343","journal-title":"Psychopharmacology"},{"key":"5543_CR4","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1021\/jm500940q","volume":"57","author":"C Bourgeois","year":"2014","unstructured":"Bourgeois C, Werfel E, Galla F et al (2014) Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted \u03ba-opioid receptor agonists. J Med Chem 57:6845\u20136860. https:\/\/doi.org\/10.1021\/jm500940q","journal-title":"J Med Chem"},{"key":"5543_CR5","doi-asserted-by":"publisher","unstructured":"Brust TF, Morgenweck J, Kim SA et al (2016) Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Sci Signal 9:ra117\u2013ra117. https:\/\/doi.org\/10.1126\/scisignal.aai8441","DOI":"10.1126\/scisignal.aai8441"},{"key":"5543_CR6","unstructured":"Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270"},{"key":"5543_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0006-8993(94)01420-M","volume":"673","author":"L Cervo","year":"1995","unstructured":"Cervo L, Samanin R (1995) Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673:242\u2013250. https:\/\/doi.org\/10.1016\/0006-8993(94)01420-M","journal-title":"Brain Res"},{"key":"5543_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF00426372","volume":"82","author":"RJ Collins","year":"1983","unstructured":"Collins RJ, Weeks JR, Cooper MM et al (1983) Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology 82:6\u201313. https:\/\/doi.org\/10.1007\/BF00426372","journal-title":"Psychopharmacology"},{"key":"5543_CR9","unstructured":"Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244"},{"key":"5543_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/ijnp\/pyy034","volume":"21","author":"AD Dunn","year":"2018","unstructured":"Dunn AD, Reed B, Guariglia C et al (2018) Structurally related kappa opioid receptor agonists with substantial differential signaling bias: neuroendocrine and behavioral effects in C57BL6 Mice. Int J Neuropsychopharmacol 21:847\u2013857. https:\/\/doi.org\/10.1093\/ijnp\/pyy034","journal-title":"Int J Neuropsychopharmacol"},{"key":"5543_CR11","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1021\/acschemneuro.9b00195","volume":"10","author":"AD Dunn","year":"2019","unstructured":"Dunn AD, Reed B, Erazo J et al (2019) Signaling properties of structurally diverse kappa opioid receptor ligands: toward in vitro models of in vivo responses. ACS Chem Neurosci 10:3590\u20133600. https:\/\/doi.org\/10.1021\/acschemneuro.9b00195","journal-title":"ACS Chem Neurosci"},{"key":"5543_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1196\/annals.1316.050","volume":"1025","author":"K Hasebe","year":"2004","unstructured":"Hasebe K, Kawai K, Suzuki T et al (2004) Possible pharmacotherapy of the opioid \u03ba receptor agonist for drug dependence. Ann N Y Acad Sci 1025:404\u2013413. https:\/\/doi.org\/10.1196\/annals.1316.050","journal-title":"Ann N Y Acad Sci"},{"key":"5543_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/IJNRD.S145720","volume":"11","author":"H Kozono","year":"2018","unstructured":"Kozono H, Yoshitani H, Nakano R (2018) Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch\u00ae capsules 2.5 \u03bcg) in 3,762 hemodialysis patients with intractable pruritus. Int J Nephrol Renovasc Dis Volume 11:9\u201324. https:\/\/doi.org\/10.2147\/IJNRD.S145720","journal-title":"Int J Nephrol Renovasc Dis Volume"},{"key":"5543_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0091-3057(96)00440-6","volume":"57","author":"MJ Kreek","year":"1997","unstructured":"Kreek MJ (1997) Opiate and cocaine addictions: challenge for pharmacotherapies. Pharmacol Biochem Behav 57:551\u2013569. https:\/\/doi.org\/10.1016\/S0091-3057(96)00440-6","journal-title":"Pharmacol Biochem Behav"},{"key":"5543_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrd897","volume":"1","author":"MJ Kreek","year":"2002","unstructured":"Kreek MJ, LaForge KS, Butelman E (2002) Pharmacotherapy of addictions. Nat Rev Drug Discov 1:710\u2013726. https:\/\/doi.org\/10.1038\/nrd897","journal-title":"Nat Rev Drug Discov"},{"key":"5543_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000341268","volume":"36","author":"H Kumagai","year":"2012","unstructured":"Kumagai H, Ebata T, Takamori K et al (2012) Efficacy and safety of a novel \u0138-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol 36:175\u2013183. https:\/\/doi.org\/10.1159\/000341268","journal-title":"Am J Nephrol"},{"key":"5543_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0014-2999(96)00961-2","volume":"321","author":"AV Kuzmin","year":"1997","unstructured":"Kuzmin AV, Semenova S, Gerrits MAF et al (1997) \u03ba-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur J Pharmacol 321:265\u2013271. https:\/\/doi.org\/10.1016\/S0014-2999(96)00961-2","journal-title":"Eur J Pharmacol"},{"key":"5543_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3758\/BF03199214","volume":"26","author":"G Lew","year":"1998","unstructured":"Lew G, Parker LA (1998) Pentobarbital-induced place aversion learning. Anim Learn Behav 26:219\u2013224. https:\/\/doi.org\/10.3758\/BF03199214","journal-title":"Anim Learn Behav"},{"key":"5543_CR19","doi-asserted-by":"publisher","first-page":"eaao4927","DOI":"10.1126\/science.aao4927","volume":"360","author":"JJ Liu","year":"2018","unstructured":"Liu JJ, Sharma K, Zangrandi L et al (2018) In vivo brain GPCR signaling elucidated by phosphoproteomics. Science (80- ) 360:eaao4927. https:\/\/doi.org\/10.1126\/science.aao4927","journal-title":"Science (80- )"},{"key":"5543_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41386-018-0155-0","volume":"44","author":"JJ Liu","year":"2019","unstructured":"Liu JJ, Chiu Y-T, DiMattio KM et al (2019) Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in \u03ba opioid aversion. Neuropsychopharmacology 44:939\u2013949. https:\/\/doi.org\/10.1038\/s41386-018-0155-0","journal-title":"Neuropsychopharmacology"},{"key":"5543_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00213-012-2912-9","volume":"226","author":"KA MacLean","year":"2013","unstructured":"MacLean KA, Johnson MW, Reissig CJ et al (2013) Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology 226:381\u2013392. https:\/\/doi.org\/10.1007\/s00213-012-2912-9","journal-title":"Psychopharmacology"},{"key":"5543_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.npp.1300860","volume":"31","author":"JP McLaughlin","year":"2006","unstructured":"McLaughlin JP, Land BB, Li S et al (2006) Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31:787\u2013794. https:\/\/doi.org\/10.1038\/sj.npp.1300860","journal-title":"Neuropsychopharmacology"},{"key":"5543_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0091-3057(97)00391-2","volume":"59","author":"SM Meehan","year":"1998","unstructured":"Meehan SM, Schechter MD (1998) LSD produces conditioned place preference in male but not female fawn hooded rats. Pharmacol Biochem Behav 59:105\u2013108. https:\/\/doi.org\/10.1016\/S0091-3057(97)00391-2","journal-title":"Pharmacol Biochem Behav"},{"key":"5543_CR24","first-page":"812","volume":"286","author":"NK Mello","year":"1998","unstructured":"Mello NK, Negus SS (1998) Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. J Pharmacol Exp Ther 286:812\u2013824","journal-title":"J Pharmacol Exp Ther"},{"key":"5543_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fphar.2019.00407","volume":"10","author":"KL Mores","year":"2019","unstructured":"Mores KL, Cummins BR, Cassell RJ, van Rijn RM (2019) A review of the therapeutic potential of recently developed G protein-biased kappa agonists. Front Pharmacol 10:407. https:\/\/doi.org\/10.3389\/fphar.2019.00407","journal-title":"Front Pharmacol"},{"key":"5543_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00213-002-1028-z","volume":"161","author":"T Mori","year":"2002","unstructured":"Mori T, Nomura M, Nagase H et al (2002) Effects of a newly synthesized \u03ba-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats. Psychopharmacology 161:17\u201322. https:\/\/doi.org\/10.1007\/s00213-002-1028-z","journal-title":"Psychopharmacology"},{"key":"5543_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bmcl.2009.11.027","volume":"20","author":"H Nagase","year":"2010","unstructured":"Nagase H, Watanabe A, Nemoto T et al (2010) Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology. Bioorg Med Chem Lett 20:121\u2013124. https:\/\/doi.org\/10.1016\/j.bmcl.2009.11.027","journal-title":"Bioorg Med Chem Lett"},{"key":"5543_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/J.BMCL.2012.10.100","volume":"23","author":"T Nemoto","year":"2013","unstructured":"Nemoto T, Yamamoto N, Wada N et al (2013) The effect of 17-N substituents on the activity of the opioid \u03ba receptor in nalfurafine derivatives. Bioorg Med Chem Lett 23:268\u2013272. https:\/\/doi.org\/10.1016\/J.BMCL.2012.10.100","journal-title":"Bioorg Med Chem Lett"},{"key":"5543_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00002826-199619050-00009","volume":"19","author":"AC Pande","year":"1996","unstructured":"Pande AC, Pyke RE, Greiner M et al (1996) Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain. Clin Neuropharmacol 19:451\u2013456. https:\/\/doi.org\/10.1097\/00002826-199619050-00009","journal-title":"Clin Neuropharmacol"},{"key":"5543_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cellsig.2017.01.016","volume":"32","author":"SS Schattauer","year":"2017","unstructured":"Schattauer SS, Kuhar JR, Song A, Chavkin C (2017) Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor. Cell Signal 32:59\u201365. https:\/\/doi.org\/10.1016\/j.cellsig.2017.01.016","journal-title":"Cell Signal"},{"key":"5543_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00213-004-1878-7","volume":"176","author":"S Stevens Negus","year":"2004","unstructured":"Stevens Negus S (2004) Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology 176:204\u2013213. https:\/\/doi.org\/10.1007\/s00213-004-1878-7","journal-title":"Psychopharmacology"},{"key":"5543_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0014-2999(01)01588-6","volume":"435","author":"Y Togashi","year":"2002","unstructured":"Togashi Y, Umeuchi H, Okano K et al (2002) Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol 435:259\u2013264. https:\/\/doi.org\/10.1016\/s0014-2999(01)01588-6","journal-title":"Eur J Pharmacol"},{"key":"5543_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1527-3458.2003.tb00248.x","volume":"9","author":"M-LG Wadenberg","year":"2003","unstructured":"Wadenberg M-LG (2003) A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. CNS Drug Rev 9:187\u2013198","journal-title":"CNS Drug Rev"},{"key":"5543_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1124\/jpet.104.073668","volume":"312","author":"Y Wang","year":"2005","unstructured":"Wang Y, Tang K, Inan S et al (2005) Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J Pharmacol Exp Ther 312:220\u2013230. https:\/\/doi.org\/10.1124\/jpet.104.073668","journal-title":"J Pharmacol Exp Ther"},{"key":"5543_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1124\/jpet.114.216820","volume":"352","author":"KL White","year":"2015","unstructured":"White KL, Robinson JE, Zhu H et al (2015) The G protein-biased \u03ba-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo. J Pharmacol Exp Ther 352:98\u2013109","journal-title":"J Pharmacol Exp Ther"},{"key":"5543_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00213-003-1688-3","volume":"172","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Butelman ER, Schlussman SD et al (2004) Effect of the endogenous \u03ba opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice. Psychopharmacology 172:422\u2013429. https:\/\/doi.org\/10.1007\/s00213-003-1688-3","journal-title":"Psychopharmacology"},{"key":"5543_CR37","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/acer.14033","volume":"43","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Kreek MJ (2019) Combination of clinically utilized kappa-opioid receptor agonist nalfurafine with low-dose naltrexone reduces excessive alcohol drinking in male and female mice. Alcohol Clin Exp Res 43:1077\u20131090. https:\/\/doi.org\/10.1111\/acer.14033","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05543-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05543-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05543-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:19:04Z","timestamp":1621495144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05543-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["5543"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05543-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animals were housed and euthanized in a manner approved by The Rockefeller University Institutional Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}